Published in Scand J Haematol on March 01, 1981
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications. Leukemia (2006) 1.74
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med (2001) 1.63
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol (1996) 1.60
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG) Br J Haematol (1991) 1.45
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol (2000) 1.22
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis. Clin Exp Immunol (1977) 1.08
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Interferon enhances the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes. J Immunol (1981) 1.04
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood (2000) 0.99
Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol (1987) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood (1984) 0.96
Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Scand J Clin Lab Invest (2003) 0.96
[Blood transfusion increases the risk of surgical infection]. Ugeskr Laeger (1993) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genet Cytogenet (1994) 0.96
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med (2003) 0.94
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leuk Res (1984) 0.91
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome. Br J Haematol (1992) 0.91
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol (1976) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol (1985) 0.89
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89
Antibody response to pneumococcal vaccine in splenectomized adults and adolescents. Acta Pathol Microbiol Immunol Scand C (1982) 0.89
Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
[Extramedullary manifestations among adult patients with acute lymphoblastic leukemia (ALL)]. Ugeskr Laeger (1991) 0.88
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer (1999) 0.88
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. Leukemia (2013) 0.87
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. In Vivo (1999) 0.87
Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem (2001) 0.87
The cellular immune response after splenectomy in humans. Impaired immunoglobulin synthesis in vitro. Scand J Haematol (1983) 0.86
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
In vitro parameters of cell-mediated immune reactions in healthy individuals following immune-stimulation attempts with levamisole. Acta Allergol (1975) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86